FBXO11.md
... ...
@@ -6,12 +6,9 @@ link-citations: true
6 6
# FBXO11
7 7
8 8
## Overview
9
-Somatic mutations in FBXO11 are common in BL<sup>1,2</sup> and appear in a small number of DLBCLs.<sup>3</sup>
10
-This gene has some recurrent sites of mutations (hot spots). Mutations lead to stabilization of BCL6, an important transcriptional repressor involved in lymphomagenesis.<sup>4</sup>
11
-These mutations present a potential novel target for therapeutic intervention, particularly through strategies aimed at degrading BCL6 or inhibiting its function.<sup>4</sup>
12
-
13
-## History
14
-Mutations in this gene were first described in BL in 2015 by Pighi et al<sup>4</sup> and in DLBCL by Hübschmann et al.<sup>5</sup>
9
+Somatic mutations in FBXO11 are common in BL[@richterRecurrentMutationID32012a] and appear in a small number of DLBCLs.[@hubschmannMutationalMechanismsShaping2021b]
10
+This gene has some recurrent sites of mutations (hot spots). Mutations lead to stabilization of BCL6, an important transcriptional repressor involved in lymphomagenesis.
11
+These mutations present a potential novel target for therapeutic intervention, particularly through strategies aimed at degrading BCL6 or inhibiting its function.
15 12
16 13
```mermaid
17 14
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%